ACS Omega
(Feb 2022)
Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma
- Pengfei Xu,
- Mike-Andrew Westhoff,
- Amina Hadzalic,
- Klaus-Michael Debatin,
- Lukasz Winiarski,
- Jozef Oleksyszyn,
- Christian Rainer Wirtz,
- Uwe Knippschild,
- Timo Burster
Affiliations
- Pengfei Xu
- Department of General and Visceral Surgery, Surgery Center, Ulm University Medical Center, Ulm, Germany
- Mike-Andrew Westhoff
- Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- Amina Hadzalic
- Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- Klaus-Michael Debatin
- Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- Lukasz Winiarski
- Faculty of Chemistry, Division of Medicinal Chemistry and Microbiology, Wroclaw University of Science and Technology, Wrocław, Poland
- Jozef Oleksyszyn
- Faculty of Chemistry, Division of Medicinal Chemistry and Microbiology, Wroclaw University of Science and Technology, Wrocław, Poland
- Christian Rainer Wirtz
- Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
- Uwe Knippschild
- Department of General and Visceral Surgery, Surgery Center, Ulm University Medical Center, Ulm, Germany
- Timo Burster
- Department of Biology, School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan Republic
- DOI
-
https://doi.org/10.1021/acsomega.1c06169
- Journal volume & issue
-
Vol. 7,
no. 7
pp.
5929
– 5936
WeChat QR code